Stock KRYS KRYSTAL BIOTECH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Krystal Biotech, Inc.

Equities

KRYS

US5011471027

Market Closed - Nasdaq
Other stock markets
 21:30:01 03/05/2024 BST 		5-day change 1st Jan Change
161.1 USD +0.54% Intraday chart for Krystal Biotech, Inc. +2.69% +29.86%
04-22 Krystal Biotech, Inc Announces First Patient Dosed in Phase 1 Clinical Trial of Inhaled KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors of the Lung CI
04-16 Stifel Adjusts Price Target on Krystal Biotech to $204 From $178, Maintains Buy Rating MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
KRYSTAL BIOTECH, INC. Stock Krystal Biotech, Inc.
 4.59B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 105B
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 104B
ARGENX SE Stock argenx SE
 22.94B -
BIONTECH SE Stock BioNTech SE
 22.34B -
GENMAB A/S Stock Genmab A/S
 19.25B
  1. Stock Market
  2. Equities
  3. KRYS Stock
  4. Charts Krystal Biotech, Inc.
  5. Sector Chart